|
|
|
|
|
|
Journal of Bacteriology, June 2002, p . 3416-3418, Vol . 184, No . 12
Requirement for NusG for Transcription Antitermination In Vivo by the
|
| ABSTRACT |
|---|
Transcription antitermination by the bacteriophage
N protein is stimulated in vitro by the Escherichia coli NusG protein . Earlier work suggested that NusG was not required for N activity in vivo . Here we present evidence that NusG also stimulates N-mediated transcription antitermination in intact cells .
| INTRODUCTION |
|---|
NusG, a 21-kDa essential protein in Escherichia coli (8, 20), is an abundant transcription elongation factor that modulates Rho-dependent transcription termination (22, 24, 25) . Rho-dependent termination is inhibited by depletion or overexpression of NusG (2, 24) . Affinity chromatography experiments showed that NusG associates with Rho or core RNA polymerase (19) . It was proposed that NusG facilitates termination by aiding in the recruitment of Rho to the transcription complex (1, 18, 21, 22, 24) .
In vitro studies identified NusG as an E . coli protein that influences transcription antitermination mediated by the N protein of phage
(18, 20) . Transcription of the
delayed early genes requires RNA polymerase to read through a number of transcription terminators . N, in complex with the E . coli Nus factors, modifies RNA polymerase at specific RNA sites, NUT, to a form that overrides downstream transcription terminators (Fig . 1) (7, 11, 12, 16, 23, 27) .
|
Nus factors were first identified by mutations in E . coli that influence N action . Mutations in nusA (nusA1) (9), nusB (a number of mutations) (10, 17), and rpsJ (nusE71) (14) reduce N activity, particularly at higher temperatures . In contrast, the nusB101 mutation suppresses this effect of the nusA1 and nusE71 alleles on N action (26) .
The only genetic evidence for a role of NusG in N antitermination was the isolation of nusG4, which has a suppressor phenotype identical to that of the nusB101 allele (25) . However, selection for nus mutations that reduce N action did not yield nusG mutants . Furthermore, in contrast to its function in vitro, in vivo studies provided evidence that NusG was not required for effective N-mediated transcription antitermination . The in vivo studies employed a strain bearing a lacZ reporter fused downstream of the
pL promoter, nutL, and transcription terminators . Because of the terminators, expression of the lacZ reporter is N dependent . NusG was expressed from a plasmid with a temperature-sensitive replicon . NusG depletion was accomplished by shifting the strain from 32 to 42°C . N was expressed from a plasmid under the control of the lac promoter . The experimental design was to supply N after depleting the bacteria of NusG (see below for the method of depletion) by treating the bacteria with IPTG (isopropyl-ß-D-thiogalactopyranoside) . Depleting this strain of NusG did not reduce lacZ expression, suggesting that N-mediated antitermination did not require NusG (24) . However, more recent experiments show that this result can be explained on the basis of leaky expression of N prior to the depletion of NusG (data not shown) . We were concerned because the plasmid supplying N was present during the entire time of growth at 42°C . Since the pL-nutL-tL1-lacZ fusion used to measure N-mediated transcription antitermination is controlled by the temperature-sensitive
cI857 repressor, transcription from pL would be active during NusG depletion . Thus, a leaky level of N expression during depletion supports read-through of the terminator and permits expression of lacZ . We avoided this problem by devising a protocol in which N was supplied only after NusG depletion had been completed .
The method of Sullivan and Gottesman was used to produce bacteria depleted of NusG (24) . Briefly, a conditionally lethal E . coli strain, K9683, was constructed by disrupting the chromosomal nusG allele with an insertion of a gene conferring resistance to kanamycin, kanR . The nusG defect is complemented with an expressible wild-type nusG gene on pSS119, a plasmid that has a thermosensitive defect in replication . As shown previously, the NusG protein in the E . coli cells can be depleted by growing the cells at 42°C in Luria-Bertani broth (15) for 6 h . The cultures were diluted every hour into fresh prewarmed Luria-Bertani broth to maintain logarithmic growth . Because the plasmid fails to replicate under these conditions, cell division segregates cells that lack the nusG plasmid and eventually the NusG protein . The control strain, K9435, carries the disrupted chromosomal nusG allele, but the nusG plasmid, pSS120, is replication proficient at high temperature . Depletion was confirmed by Western blotting . As shown in Fig . 2, K9683 and K9435 grown at 32°C contained similar quantities of NusG protein . However, when the bacteria were grown at 42°C, NusG was undetectable in strain K9683, which carries the temperature-sensitive nusG plasmid, whereas no decrease in NusG concentration was observed in the control strain, K9435 .
|
We assessed the role of NusG in N antitermination by infecting K9435 and K9863 with four
variants .
,
nusG, and
cam all require N; they fail to grow in E . coli carrying the nusA1, nusB5, or nusE71 mutation at the nonpermissive temperature (reference 14 and data not shown) .
nin has a deletion of a critical set of transcription terminators (Fig . 1) and thus can grow independently of N (3, 4) . As expected,
nin grows in the three nus mutant strains (reference 14 and data not shown) .
nusG is identical to
cam but carries a nusG gene instead of cat .
nusG is expected to grow in an E . coli strain depleted of NusG even if NusG is required for N action .
cam serves as a control for
nusG (see the legend to Fig . 1) . Phage growth was determined by measuring burst size (phage produced per infected bacterium) 90 min after infection (13) . The results of these experiments are shown in Table 1 . The burst sizes of
and
nin at 42°C are the same in the control strain, K9435, where NusG is present . However, the burst size of
is
30-fold lower than that of
nin in strain K9683, which is depleted of NusG at 42°C . Note that the burst size of
nin is reduced in K9683 relative to that produced in K9435, likely reflecting the unfavorable environment provided by a bacterium growing in the near absence of NusG .
nin, then, provides a way to assess the effectiveness of bacteria depleted of NusG in supporting growth of
independently of the requirement for N-mediated antitermination; i.e., the nin phage is the positive control . In summary, these data suggest that poorer growth of
in NusG-depleted E . coli is due to a failure of N-mediated transcription antitermination over and above that caused by the failing physiological environment .
|
To show that N would be effective if NusG were present in a NusG-depleted bacterium, we compared growth of
nusG and
cam in the absence of NusG . Since these phages are essentially identical except for the ability of the former to express NusG, support of growth of
nusG but not
cam would be evidence that NusG is required for
growth . The bursts of these two phages were the same when grown in the host K9435, which expresses NusG at 42°C . However, the burst of
cam is
30-fold lower than the burst of
nusG in K9683 depleted of NusG by prior growth at 42°C .
Thus, the defect in N activity in K9683 can be corrected by expressing NusG . The 10-fold-lower burst of
nusG in K9683 relative to K9435 is not unexpected, since NusG is supplied to the depleted bacterium only during the short time of infection .
Taken together, these observations indicate that NusG is required for N action . First, the low burst of
relative to
nin in K9683 provides evidence that N-mediated transcription antitermination is reduced in vivo in the absence of NusG . Second, the ability of
nusG to grow in K9683 shows that the absence of NusG is responsible for the failure of N antitermination . We conclude, therefore, that NusG is required for N-mediated antitermination in vivo as it is in vitro .
| ACKNOWLEDGMENTS |
|---|
Jack Greenblatt is thanked for anti-NusG antiserum .
The work at the University of Michigan was supported by Public Health Research grant A111459-10 . M.E.G . is the recipient of NIH grant GM37219 .
| FOOTNOTES |
|---|
* Corresponding author . Mailing address: Department of Microbiology and Immunology, University of Michigan, 5641 Medical Science Bldg . II, Ann Arbor, MI 48109-0620 . Phone: (734) 769-0181 . Fax: (734) 764-3562 . E-mail: davidfri{at}umich.edu .
| REFERENCES |
|---|
What Is Water Purification?,
What Is Growth Medium?,
What Is Prokaryote?,
What Is Genetic Engineering?,
What Is MIC?,
c,
Bacteria,
e,
Microbiology,
c,
Microbe,
c,
Bacteriology,
c,
Microbes,
a,
Bacteriophages,
r,
Streptomycin,
e,
Microbial,
r,
Erythromycin,
i,
Alcaligenes,
n,
Escherichia coli,
s,
Cell suspensions,
i,
Prokaryotes,
n,
Escherichia coli,
a,
Escherichia coli,
i,
Escherichia coli,
c,
Escherichia coli,
c,
Bacteriophage,
n,
Schizosaccharomyces,
n,
Streptococci,
r,
Microbial,
c,
Haemophilus,
n,
S. cerevisiae,
a,
Antibiotics,
n,
Escherichia coli,
e,
Escherichia coli
© 2005
Transgalactic Ltd (manufacturer of Bioscreen C software) |
Privacy Statement | P.O. Box
1393, 00101 Helsinki, Finland,
Last modified: May 25, 2005
| ||||||
